Burkitt lymphoma treatment focuses on rapidly controlling the spread of highly aggressive cancer cells originating from B-lymphocytes. This form of non-Hodgkin lymphoma grows and multiplies quickly, making early diagnosis and intensive therapy essential.
Treatment options typically include combination chemotherapy, immunotherapy (such as rituximab), targeted therapy, and, in selected cases, stem cell transplant or CNS prophylaxis (to prevent cancer from spreading to the brain and spinal cord). Supportive care is also vital to manage side effects and maintain strength during treatment.
Burkitt lymphoma progresses much faster than most other lymphomas, but it also responds well to prompt, high-intensity treatment. Many patients achieve remission when therapy begins early and is closely monitored by specialists.
The main types of Burkitt lymphoma include:
Doctors customise the treatment plan based on the type of Burkitt lymphoma, disease stage, patient’s age, overall health, and response to initial therapy.
The goal of treatment is to achieve complete remission, prevent relapse, and improve long-term survival. Early and aggressive therapy offers the best outcomes for patients with Burkitt lymphoma.
Burkitt lymphoma treatment is essential because this cancer grows and spreads extremely fast. Without immediate medical intervention, it can quickly affect vital organs. The aggressive nature of Burkitt lymphoma can lead to life-threatening complications within weeks if untreated.
Prompt and intensive treatment helps destroy cancer cells, prevent further spread, relieve symptoms, and improve survival outcomes. Early diagnosis and timely therapy are critical for achieving remission and maintaining long-term health.
The exact cause of Burkitt lymphoma is not completely known, but several factors are believed to increase the risk of developing this aggressive cancer:
Weakened immune system
Burkitt lymphoma symptoms develop suddenly and progress rapidly due to the fast-growing nature of the disease. Common warning signs include:
Because Burkitt lymphoma progresses quickly, immediate diagnosis and intensive treatment are essential for recovery and long-term survival.
Doctors recommend starting Burkitt lymphoma treatment immediately after diagnosis, as this cancer grows and spreads very rapidly. Unlike some slow-growing lymphomas, watchful waiting is not suitable for Burkitt lymphoma. Treatment usually begins as soon as test results confirm the disease.
Treatment is initiated when:
Because Burkitt lymphoma advances within days or weeks, early and intensive therapy is crucial to control the disease and prevent complications. Patients can connect with myheco for expert guidance, hospital recommendations, and support in finding the right lymphoma specialists and treatment plans.
Many hospitals worldwide provide specialised care for patients with Burkitt lymphoma, combining advanced cancer treatment facilities with experienced multidisciplinary teams. These centres have expert haematologists, oncologists, paediatric oncology specialists, and bone marrow transplant units equipped to manage this fast-growing lymphoma with precision and care.
Some of the leading hospitals for Burkitt lymphoma treatment include:
.png)
.png)
These hospitals follow internationally approved protocols for Burkitt lymphoma treatment and are fully equipped to support patients through every stage, from rapid diagnosis and disease staging to intensive chemotherapy, immunotherapy, CNS prophylaxis, stem cell transplant, and long-term follow-up care.
The average cost of Burkitt lymphoma treatment ranges from $5,900 to $12,000 in India and $9,400 to $22,000 in Thailand. The total expense can vary depending on factors such as the patient’s age, disease stage, treatment intensity, hospital selection, and the need for advanced therapies like high-dose chemotherapy, immunotherapy, CNS prophylaxis, or stem cell transplant.
Before reviewing the treatment-wise cost table, it is important to consider key factors that influence overall expenses, including diagnostic tests, hospital stay, type of medications, supportive care, and post-treatment follow-up.
Several factors can affect the total cost of Burkitt lymphoma treatment:
Early diagnosis and a personalised treatment plan can improve survival outcomes and help manage costs effectively.
Note: India has become a preferred destination for advanced cancer treatment, offering world-class care at a fraction of the international cost. Patients benefit from expert oncologists, modern medical technology, and affordable access to high-quality generic medicines, making treatment both effective and economical.
Note: Thailand has established itself as a premium destination for cancer treatment, offering world-class hospitals, advanced technology, and internationally trained oncologists. Patients choose Thailand not only for its high-quality medical care but also for its holistic approach, combining clinical excellence with exceptional comfort and service standards.
The above figures are approximate and can vary based on the hospital, location, and individual patient requirements. Always consult the healthcare provider for the most accurate and up-to-date pricing.
The currency conversion rates in the table above are based on data from January 2026.
For a detailed cost estimate and guidance on treatment options, patients can contact myheco to connect with leading hospitals.
Burkitt’s Lymphoma (BL) shows varying survival rates across different age groups. Five-year relative survival is highest in children (<15 years) at 90.4%, while it drops to 47.8% in adults (40-70 years) and further to 28.9% in the elderly (>70 years). Survival is influenced by disease stage and presence of multiple primaries, with advanced stages and additional cancers linked to higher mortality. These statistics highlight that younger patients generally achieve the best outcomes, while adults and the elderly require more intensive management to improve survival chances.
Leading hospitals provide patient-focused, intensive care with accurate diagnostics, personalised treatment plans, and continuous support. Their approach includes:
This integrated, high-intensity approach helps control disease progression, reduces relapse risk, and improves long-term survival and quality of life for patients with Burkitt lymphoma.
According to Dr Padmaja, Consultant, Haemato-Oncology and Bone Marrow Transplant at Apollo Cancer Centre, Jubilee Hills, Hyderabad, Burkitt lymphoma is one of the high-grade (aggressive) non-Hodgkin lymphomas, meaning it progresses rapidly and requires immediate treatment. Unlike slow-growing (low-grade) lymphomas that may relapse over time, high-grade types such as Burkitt’s are potentially curable when treated promptly and appropriately.
Myheco helps international patients access world-class Burkitt lymphoma care by connecting them with experienced specialists, guiding them through personalised treatment planning, and coordinating every step of their medical journey. Patients receive seamless, transparent, and tailored support at every stage.
Choosing myheco means expert care, faster access, and comprehensive support throughout your treatment journey.
Note: Myheco does not provide medical advice.
✅ Share your medical reports
✅ Receive personalised treatment plans from leading hospitals
✅ Choose the option that suits you best
✅ Let us handle the arrangements
Burkitt lymphoma is an aggressive but highly treatable cancer. With early diagnosis and intensive therapy, many patients, especially children, can achieve complete remission and long-term survival.
Treatment depends on the patient’s age, disease stage, and overall health. Options typically include intensive combination chemotherapy, immunotherapy (rituximab), CNS prophylaxis, targeted therapy, and stem cell transplant in select cases. Rapid treatment initiation is crucial due to the fast-growing nature of the disease.
Recovery varies depending on treatment intensity. High-dose chemotherapy may require hospitalisation and close monitoring, followed by regular follow-ups to assess remission and prevent relapse.
There is no guaranteed prevention for Burkitt lymphoma. Early detection and prompt, intensive treatment are key to improving outcomes. Managing immune health and monitoring high-risk patients may help in early identification.
Myheco supports patients by arranging online consultations, providing second opinions, connecting with top haematologists and oncology specialists, offering detailed cost estimates, issuing medical visa invitation letters, coordinating travel and hospital transfers, and providing multilingual support throughout the treatment journey.
India has several hospitals providing specialised care for Burkitt lymphoma. In Chennai, leading centres include SIMS Hospital, MGM Healthcare, Apollo Cancer Institute, and Apollo Proton Cancer Centre. In Bangalore, Manipal Hospital Main Oncology Unit offers high-dose chemotherapy and stem cell transplant. In Delhi, hospitals such as Manipal Hospital Dwarka, Max Super Speciality Hospital Saket, and BLK-Max Hospital are recognised for multidisciplinary Burkitt lymphoma care. In Mumbai, Nanavati Max Hospital is trusted for advanced haematology and oncology services, while in Kolkata, Manipal Hospitals EM Bypass (Medica Synergie Cancer Hospital) is renowned for expert management of aggressive lymphomas.
In Thailand, Samitivej Sukhumvit Hospital and Samitivej Srinakarin Hospital are highly recommended for Burkitt lymphoma care. Both hospitals provide world-class facilities and expertise in intensive chemotherapy, immunotherapy (rituximab), CNS prophylaxis, targeted therapy, and stem cell transplantation when needed. These hospitals ensure comprehensive, timely, and effective care for patients with Burkitt lymphoma.
DISCLAIMER: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE
The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material or content on this site is intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website - www.myheco.com
.png)